|1.||Cross, Amanda J: 1 article (04/2015)|
|2.||Zhang, Zhiying: 1 article (04/2015)|
|3.||Colburn, Nancy H: 1 article (04/2015)|
|4.||Hartman, Terryl J: 1 article (04/2015)|
|5.||Murphy, Gwen: 1 article (04/2015)|
|6.||Bobe, Gerd: 1 article (04/2015)|
|7.||Perera, Thushanthi: 1 article (04/2015)|
|8.||Young, Matthew R: 1 article (04/2015)|
|9.||Lanza, Elaine: 1 article (04/2015)|
|10.||Bauer, M L: 1 article (06/2011)|
|1.||Chronic Obstructive Pulmonary Disease (COPD)
10/01/2008 - "This indication differs from that for carbocisteine and mecysteine, two older mucolytic drugs that are licensed for adjunctive treatment in respiratory disorders characterised by viscous mucus, and typically used for longer to prevent exacerbations of chronic obstructive pulmonary disease (COPD). "
10/08/1978 - "Thus, in this study, letosteine (50 mg t.i.d.) appeared equivalent to S-carboxy-methyl-cysteine (750 mg t.i.d.) in the treatment of chronic obstructive lung disease in adults."
10/08/1978 - "A controlled double-blind clinical trial comparing a noval medicament, letosteine, to a known bronchial fluidifier, S-carboxy-methyl-cysteine, was conducted on a total of 47 hospitalized patients suffering from various types of chronic obstructive lung disease. "
04/01/2015 - "The serum metabolites identified in these controlled feeding studies were then investigated in 212 polyp-free participants from the Polyp Prevention Trial who self-reported either increased (≥+31 g/day from baseline), high dry bean intake of ≥42 g/day in year 3 or low, unchanged dry bean consumption of <8 g/day; serum was analyzed from baseline and year 3. Serum pipecolic acid and S-methyl cysteine were elevated after dry bean consumption in human and mouse studies and reflected dry bean consumption in the Polyp Prevention Trial. "
11/27/1978 - "Effect of the mucoregulator S-carboxy-methyl-cysteine in patients with chronic bronchitis."
02/03/1962 - "Clinical trial of methyl cysteine hydrochloride in chronic bronchitis."
11/27/1978 - "Twenty patients with stable chronic bronchitis entered a double-blind study in which changes in clinical and respiratory function and biochemical and rheological variations were examined after treatment with the mucoregulator S-carboxy-methyl-cysteine (S.C.M.C.). "
11/01/1973 - "[Use of an S-carboxy-methyl-cysteine and theophylline combination in the treatment of chronic bronchitis]."
|5.||S-allylcysteine (allyl cysteine)